Comments to the Article Wu Y, Völler S, Goulooze SC, et al. A Novel Maturation Equation for Hepatic Clearance Across Preterm, Term Neonates, Children, and Adults: Application to Paracetamol and Its Metabolite. J Clin Pharmacol. 2025;65(12):1829‐1843.

A recent article in this journal by Wu et al presented a comprehensive model for the maturation of paracetamol clearance from birth to adulthood using pooled plasma and urinary data of the parent drug and its metabolites from 298 subjects. The modeling showed that the oxidative bioactivation to hepatotoxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) is generally around 10% of the total clearance. We would like to comment on the authors' discussion on the formation of NAPQI, which highlights once again the main role of CYP2E1 in the oxidative bioactivation metabolism of paracetamol. CYP2E1 was demonstrated as a primary catalyst in the bioactivation of paracetamol, referring only to the paper of Johnsrud et al, that describes only the developmental phase of CYP2E1 in man.

Authors

Institutions

Publication Details

Journal
The Journal of Clinical Pharmacology
Published
2026-05-01
DOI
https://doi.org/10.1002/jcph.70206
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comments to the Article Wu Y, Völler S, Goulooze SC, et al. A Novel Maturation Equation for Hepatic Clearance Across Preterm, Term Neonates, Children, and Adults: Application to Paracetamol and Its Metabolite. J Clin Pharmacol. 2025;65(12):1829‐1843.

Risto Juvonen, Markku Pasanen
The Journal of Clinical Pharmacology
Pharmacogenetics and Drug Metabolism
article

Comments to the Article Wu Y, Völler S, Goulooze SC, et al. A Novel Maturation Equation for Hepatic Clearance Across Preterm, Term Neonates, Children, and Adults: Application to Paracetamol and Its Metabolite. J Clin Pharmacol. 2025;65(12):1829‐1843.

Risto Juvonen, Markku Pasanen
article en

Abstract

A recent article in this journal by Wu et al presented a comprehensive model for the maturation of paracetamol clearance from birth to adulthood using pooled plasma and urinary data of the parent drug and its metabolites from 298 subjects. The modeling showed that the oxidative bioactivation to hepatotoxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) is generally around 10% of the total clearance. We would like to comment on the authors' discussion on the formation of NAPQI, which highlights once again the main role of CYP2E1 in the oxidative bioactivation metabolism of paracetamol. CYP2E1 was demonstrated as a primary catalyst in the bioactivation of paracetamol, referring only to the paper of Johnsrud et al, that describes only the developmental phase of CYP2E1 in man.

The Journal of Clinical PharmacologyVol. 66(5)
University of Eastern Finland (FI)
Good health and well-being
Openalex Percentile: Top 6%
Pharmacogenetics and Drug Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comments to the Article Wu Y, Völler S, Goulooze SC, et al. A Novel Maturation Equation for Hepatic Clearance Across Preterm, Term Neonates, Children, and Adults: Application to Paracetamol and Its Metabolite. J Clin Pharmacol. 2025;65(12):1829‐1843. — Risto Juvonen, Markku Pasanen · The Journal of Clinical Pharmacology (2026) | TGRS Research Map | TGRS